BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Vivera Pharmaceuticals Receives U.S. Patent (US 11,083,850) for ZICOH®

  Vivera Pharmaceuticals, Inc. (Vivera) today announced that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,083,850 for ZICOH®, the Company’s wireless, electronic, dose-controlled medication delivery device.

  August 20, 2021

   · 

  3 min read
• BioCapital

  Adial Pharmaceuticals to Host Conference Call Today at 11AM Eastern to Provide Clinical Update and Discuss Positive Business Developments

  Adial Pharmaceuticals, Inc. will host a conference call at 11:00 A.M. Eastern Time today, August 20, 2021 to provide a clinical update and discuss the latest business developments.

  August 20, 2021

   · 

  1 min read
• Business

  Nexteligent Submits June 30, 2021 Quarterly Filing to OTC Markets

  Nexteligent Holdings, Inc. (OTC: NXGT) has submitted its June 30, 2021 Quarterly filing with OTCMarkets.com to remain in compliance.

  August 20, 2021

   · 

  1 min read
• Cardiac Rehabilitation Market to Rise at 6.2% CAGR While Angioplasty Segment to Hit 1,780.98 million to 2028

  The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.2% during 2021–2028.

  August 20, 2021

   · 

  4 min read
• Pharm Country

  Breckenridge Pharmaceutical, Inc. Announces Launch of Norepinephrine Bitartrate Injection, USP (generic for Levophed®)

  Breckenridge Pharmaceutical, Inc. announces today that it has launched Norepinephrine Bitartrate Injection, USP (generic for Levophed ® ), manufactured by Rafarm S.A.

  August 20, 2021

   · 

  1 min read
• Dental Burs and Endodontic Market to Reach $2.12 Billion by 2028 at 6.7% CAGR

  Ascend in commonness of dental problems, expansion in number of dental specialists, and flood in dental the travel industry and mindfulness toward oral wellbeing fuel the worldwide dental brambles and endodontic market.

  August 20, 2021

   · 

  5 min read
• Patient Monitoring Devices Market Proceeds to Reach $44.86 Billion by 2027

  Flood in use of remote observing gadgets across the globe drives the development of the worldwide patient checking gadgets market.

  August 20, 2021

   · 

  4 min read
• Genetown

  Editas Medicine Presents Data on New SLEEK Gene Editing Technology at Cold Spring Harbor Laboratory’s Genome Engineering: CRISPR Frontiers Meeting

  Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced data on a new gene editing technology termed SLEEK (SeLection by Essential-gene Exon Knock-in).

  August 20, 2021

   · 

  5 min read